Microbiological diagnosis of Clostridioides difficile infec- tion in times of COVID-19 in a high complexity pediatric hospital
Acta Bioquimica Clinica Latinoamericana
; 56(3):309-313, 2022.
Article
in English
| Web of Science | ID: covidwho-20240879
ABSTRACT
Clostridioides difficile infection (CDI) can cause anything from diarrhea to toxic megacolon. The objectives of this study were to show the varia-tion in the number of diagnosed cases of CDI in this center, comparing 2020, when the COVID-19 pandemic began, with 2019 and 2021 and to detail cases preceded by SARS-CoV-2 infection. This is an observational retrospective study in which the total number of samples processed with suspected CDI were recorded. The positive ones and the clinical history of patients with a diagnosis of CDI up to two months after their diagnosis of SARS-CoV-2 infection were recorded as well. During 2020 a smaller number of samples were processed. However, during this year the percentage of positivity was 13.1% vs. 7,2% and 7.8% during 2019 and 2021, respectively. It is believed that this may have been due to improvements in clinical suspicion and sample selection for CDI diagnosis.
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
Acta Bioquimica Clinica Latinoamericana
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS